357 related articles for article (PubMed ID: 16419166)
1. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
World J Gastroenterol; 2005 Oct; 11(40):6360-5. PubMed ID: 16419166
[TBL] [Abstract][Full Text] [Related]
2. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
Mohammed IA; Streutker CJ; Riddell RH
Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
[TBL] [Abstract][Full Text] [Related]
3. Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.
Chang Y; Liu B; Liu GS; Wang T; Gong J
World J Gastroenterol; 2010 Dec; 16(48):6151-4. PubMed ID: 21182233
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.
Couvelard A; Cauvin JM; Goldfain D; Rotenberg A; Robaszkiewicz M; Fléjou JF;
Gut; 2001 Dec; 49(6):761-6. PubMed ID: 11709508
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI.
Glickman JN; Wang H; Das KM; Goyal RK; Spechler SJ; Antonioli D; Odze RD
Am J Surg Pathol; 2001 Jan; 25(1):87-94. PubMed ID: 11145256
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus.
Gulmann C; Shaqaqi OA; Grace A; Leader M; Patchett S; Butler D; Kay E
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):142-7. PubMed ID: 15354740
[TBL] [Abstract][Full Text] [Related]
8. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
Jovanovic I; Tzardi M; Mouzas IA; Micev M; Pesko P; Milosavljevic T; Zois M; Sganzos M; Delides G; Kanavaros P
Histol Histopathol; 2002 Apr; 17(2):445-54. PubMed ID: 11962749
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.
Ormsby AH; Goldblum JR; Rice TW; Richter JE; Falk GW; Vaezi MF; Gramlich TL
Hum Pathol; 1999 Mar; 30(3):288-94. PubMed ID: 10088547
[TBL] [Abstract][Full Text] [Related]
11. Short segment Barrett's esophagus and distal gastric intestinal metaplasia.
Dietz J; Chaves-E-Silva S; Meurer L; Sekine S; de Souza AR; Meine GC
Arq Gastroenterol; 2006; 43(2):117-20. PubMed ID: 17119666
[TBL] [Abstract][Full Text] [Related]
12. Etiology of intestinal metaplasia at the gastroesophageal junction.
Balaji NS; DeMeester SR; Wickramasinghe KS; Hagen JA; Peters JH; DeMeester TR
Surg Endosc; 2003 Jan; 17(1):43-8. PubMed ID: 12364989
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
Ormsby AH; Vaezi MF; Richter JE; Goldblum JR; Rice TW; Falk GW; Gramlich TL
Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
[TBL] [Abstract][Full Text] [Related]
14. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
[TBL] [Abstract][Full Text] [Related]
15. [Cytokeratin immunoreactivity patterns in the diagnosis of Barrett's esophagus].
Wang R; Xie J; Shen Y; Ren T
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1820-3. PubMed ID: 23268419
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
17. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
Byrne JP; Bhatnagar S; Hamid B; Armstrong GR; Attwood SE
Am J Gastroenterol; 1999 Jan; 94(1):98-103. PubMed ID: 9934738
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
Yagi K; Nakamura A; Sekine A
J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
[TBL] [Abstract][Full Text] [Related]
20. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
